View in EDS

The anticholinergic burden in patients with chronic kidney disease: Patterns, risk factors, and the link with cognitive impairment.

Saved in:
Bibliographic Details
Title: The anticholinergic burden in patients with chronic kidney disease: Patterns, risk factors, and the link with cognitive impairment.
Authors: Mouheb, Agathe, Levassort, Hélène, Massy, Ziad A., Jacquelinet, Christian, Laville, Maurice, Alencar de Pinho, Natalia, Pépin, Marion, Laville, Solène M., Liabeuf, Sophie, Cannet, Dorothée, Combe, Christian, Fouque, Denis, Frimat, Luc, Hamroun, Aghilès, Herpe, Yves‐Edouard, Lambert, Oriane, Lange, Céline, Metzger, Marie, Morel, Pascal, Pascal, Christophe
Source: Journal of the American Geriatrics Society. Feb2025, Vol. 73 Issue 2, p533-544. 12p.
Subjects: Chronic kidney failure complications, Cognition disorder risk factors, Parasympathomimetic agents, Risk assessment, Medical prescriptions, Research funding, Questionnaires, Severity of illness index, Longitudinal method, Cognition disorders
Abstract: Background: People with chronic kidney disease (CKD) have an elevated risk of cognitive impairment (CI). Medications with anticholinergic activity are recognized for their adverse reactions on central nervous system. The putative association between the anticholinergic burden and CI has not previously been evaluated in patients with CKD. The study aimed to (i) describe prescriptions of medications with anticholinergic activity, (ii) analyze factors associated with these prescriptions, and (iii) evaluate the anticholinergic burden's association with cognitive performance. Methods: CKD‐REIN, a prospective cohort study, enrolled nephrology outpatients with a confirmed diagnosis of CKD (eGFR <60 mL/min/1.73m2). Drug prescriptions were recorded prospectively during the 5‐year follow‐up. Mini Mental State Examination (MMSE) was assessed at baseline and CI was defined as an MMSE score <24/30. For each patient, the anticholinergic burden was determined by summing the Anticholinergic Cognitive Burden (ACB) scores of all prescription drugs at baseline. Multinomial logistic regression was used to analyze factors associated with the ACB score. Logistic regression was used to evaluate the association between the cognitive impairment and the anticholinergic burden at baseline. Results: At baseline, 3007 patients (median age [IQR], 69[60–76]; 65% men) had MMSE data and were included. 1549 (52%) of these patients were taking at least one drug with anticholinergic properties. Most (1092; 70%) had a low anticholinergic burden, 294 (19%) had a moderate anticholinergic burden, and 163 (11%) had a high anticholinergic burden. A history of neurological/psychiatric disorders and a higher number of daily drugs were associated with a greater probability of having a high anticholinergic burden (odds ratio (OR) [95% confidence interval (95% CI)] = 1.88[1.29;2.74] and 1.53[1.45;1.61], respectively). Patients with a high anticholinergic burden had a significantly higher probability of presenting cognitive impairment, compared with patients without an anticholinergic burden (OR[95% CI] = 1.76[1.12;2.75]) after adjustment for sociodemographic factors, comorbidities, laboratory data, and the number of medications taken daily. Conclusions: The results of our study emphasize the need for caution in the prescription of drugs with anticholinergic properties to patients with CKD. [ABSTRACT FROM AUTHOR]
Copyright of Journal of the American Geriatrics Society is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 183985999
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The anticholinergic burden in patients with chronic kidney disease: Patterns, risk factors, and the link with cognitive impairment.
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Mouheb%2C+Agathe%22&quot;&gt;Mouheb, Agathe&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Levassort%2C+H&#233;l&#232;ne%22&quot;&gt;Levassort, H&#233;l&#232;ne&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Massy%2C+Ziad+A%2E%22&quot;&gt;Massy, Ziad A.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Jacquelinet%2C+Christian%22&quot;&gt;Jacquelinet, Christian&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Laville%2C+Maurice%22&quot;&gt;Laville, Maurice&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Alencar+de+Pinho%2C+Natalia%22&quot;&gt;Alencar de Pinho, Natalia&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22P&#233;pin%2C+Marion%22&quot;&gt;P&#233;pin, Marion&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Laville%2C+Sol&#232;ne+M%2E%22&quot;&gt;Laville, Sol&#232;ne M.&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Liabeuf%2C+Sophie%22&quot;&gt;Liabeuf, Sophie&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Cannet%2C+Doroth&#233;e%22&quot;&gt;Cannet, Doroth&#233;e&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Combe%2C+Christian%22&quot;&gt;Combe, Christian&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Fouque%2C+Denis%22&quot;&gt;Fouque, Denis&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Frimat%2C+Luc%22&quot;&gt;Frimat, Luc&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Hamroun%2C+Aghil&#232;s%22&quot;&gt;Hamroun, Aghil&#232;s&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Herpe%2C+Yves‐Edouard%22&quot;&gt;Herpe, Yves‐Edouard&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Lambert%2C+Oriane%22&quot;&gt;Lambert, Oriane&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Lange%2C+C&#233;line%22&quot;&gt;Lange, C&#233;line&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Metzger%2C+Marie%22&quot;&gt;Metzger, Marie&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Morel%2C+Pascal%22&quot;&gt;Morel, Pascal&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Pascal%2C+Christophe%22&quot;&gt;Pascal, Christophe&lt;/searchLink&gt;
– Name: TitleSource
  Label: Source
  Group: Src
  Data: &lt;searchLink fieldCode=&quot;JN&quot; term=&quot;%22Journal+of+the+American+Geriatrics+Society%22&quot;&gt;Journal of the American Geriatrics Society&lt;/searchLink&gt;. Feb2025, Vol. 73 Issue 2, p533-544. 12p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Chronic+kidney+failure+complications%22&quot;&gt;Chronic kidney failure complications&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Cognition+disorder+risk+factors%22&quot;&gt;Cognition disorder risk factors&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Parasympathomimetic+agents%22&quot;&gt;Parasympathomimetic agents&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Risk+assessment%22&quot;&gt;Risk assessment&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Medical+prescriptions%22&quot;&gt;Medical prescriptions&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Research+funding%22&quot;&gt;Research funding&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Questionnaires%22&quot;&gt;Questionnaires&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Severity+of+illness+index%22&quot;&gt;Severity of illness index&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Longitudinal+method%22&quot;&gt;Longitudinal method&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Cognition+disorders%22&quot;&gt;Cognition disorders&lt;/searchLink&gt;
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background: People with chronic kidney disease (CKD) have an elevated risk of cognitive impairment (CI). Medications with anticholinergic activity are recognized for their adverse reactions on central nervous system. The putative association between the anticholinergic burden and CI has not previously been evaluated in patients with CKD. The study aimed to (i) describe prescriptions of medications with anticholinergic activity, (ii) analyze factors associated with these prescriptions, and (iii) evaluate the anticholinergic burden&#39;s association with cognitive performance. Methods: CKD‐REIN, a prospective cohort study, enrolled nephrology outpatients with a confirmed diagnosis of CKD (eGFR &lt;60 mL/min/1.73m2). Drug prescriptions were recorded prospectively during the 5‐year follow‐up. Mini Mental State Examination (MMSE) was assessed at baseline and CI was defined as an MMSE score &lt;24/30. For each patient, the anticholinergic burden was determined by summing the Anticholinergic Cognitive Burden (ACB) scores of all prescription drugs at baseline. Multinomial logistic regression was used to analyze factors associated with the ACB score. Logistic regression was used to evaluate the association between the cognitive impairment and the anticholinergic burden at baseline. Results: At baseline, 3007 patients (median age [IQR], 69[60–76]; 65% men) had MMSE data and were included. 1549 (52%) of these patients were taking at least one drug with anticholinergic properties. Most (1092; 70%) had a low anticholinergic burden, 294 (19%) had a moderate anticholinergic burden, and 163 (11%) had a high anticholinergic burden. A history of neurological/psychiatric disorders and a higher number of daily drugs were associated with a greater probability of having a high anticholinergic burden (odds ratio (OR) [95% confidence interval (95% CI)] = 1.88[1.29;2.74] and 1.53[1.45;1.61], respectively). Patients with a high anticholinergic burden had a significantly higher probability of presenting cognitive impairment, compared with patients without an anticholinergic burden (OR[95% CI] = 1.76[1.12;2.75]) after adjustment for sociodemographic factors, comorbidities, laboratory data, and the number of medications taken daily. Conclusions: The results of our study emphasize the need for caution in the prescription of drugs with anticholinergic properties to patients with CKD. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: &lt;i&gt;Copyright of Journal of the American Geriatrics Society is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder&#39;s express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=183985999
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/jgs.19283
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 533
    Subjects:
      – SubjectFull: Chronic kidney failure complications
        Type: general
      – SubjectFull: Cognition disorder risk factors
        Type: general
      – SubjectFull: Parasympathomimetic agents
        Type: general
      – SubjectFull: Risk assessment
        Type: general
      – SubjectFull: Medical prescriptions
        Type: general
      – SubjectFull: Research funding
        Type: general
      – SubjectFull: Questionnaires
        Type: general
      – SubjectFull: Severity of illness index
        Type: general
      – SubjectFull: Longitudinal method
        Type: general
      – SubjectFull: Cognition disorders
        Type: general
    Titles:
      – TitleFull: The anticholinergic burden in patients with chronic kidney disease: Patterns, risk factors, and the link with cognitive impairment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mouheb, Agathe
      – PersonEntity:
          Name:
            NameFull: Levassort, Hélène
      – PersonEntity:
          Name:
            NameFull: Massy, Ziad A.
      – PersonEntity:
          Name:
            NameFull: Jacquelinet, Christian
      – PersonEntity:
          Name:
            NameFull: Laville, Maurice
      – PersonEntity:
          Name:
            NameFull: Alencar de Pinho, Natalia
      – PersonEntity:
          Name:
            NameFull: Pépin, Marion
      – PersonEntity:
          Name:
            NameFull: Laville, Solène M.
      – PersonEntity:
          Name:
            NameFull: Liabeuf, Sophie
      – PersonEntity:
          Name:
            NameFull: Cannet, Dorothée
      – PersonEntity:
          Name:
            NameFull: Combe, Christian
      – PersonEntity:
          Name:
            NameFull: Fouque, Denis
      – PersonEntity:
          Name:
            NameFull: Frimat, Luc
      – PersonEntity:
          Name:
            NameFull: Hamroun, Aghilès
      – PersonEntity:
          Name:
            NameFull: Herpe, Yves‐Edouard
      – PersonEntity:
          Name:
            NameFull: Lambert, Oriane
      – PersonEntity:
          Name:
            NameFull: Lange, Céline
      – PersonEntity:
          Name:
            NameFull: Metzger, Marie
      – PersonEntity:
          Name:
            NameFull: Morel, Pascal
      – PersonEntity:
          Name:
            NameFull: Pascal, Christophe
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: Feb2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 00028614
          Numbering:
            – Type: volume
              Value: 73
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of the American Geriatrics Society
              Type: main
ResultId 1